As of March 5, we've updated our corporate brand. We are in the process of updating our media library - in the meantime, please find new materials below.
updated Jan 2019
*This non-GAAP amount excludes significant upfront and milestone payments for business development transactions and other specified R&D items.
OPDIVO®, $6.7 billion
ELIQUIS®, $6.4 billion
ORENCIA®câu lạc bộ nohu88, $2.7 billion
SPRYCEL®, $2.0 billion
YERVOY®, $1.3 billion
BARACLUDE®câu lạc bộ nohu88, $744 million
SUSTIVA®câu lạc bộ nohu88 franchise, $283 million
REYATAZ® franchise, $427 million
Hepatitis C franchise, $17 million
Please click on the product links to see the Full Prescribing Information for , ,, , , , , , , and , including Boxed WARNINGS for , , and Boxed WARNINGS for regarding immune-mediated adverse reaction.
Bristol Myers Squibb Corporate B-roll
This B-roll includes a collection of footage of Bristol Myers Squibb campus exteriors, corporate signage, research and development, and manufacturing facilities.